Amit Bar-Or

Breakthrough in MS treatment

Published: 9Jan2017

In separate clinical trials, a drug called ocrelizumab has been shown to reduce new attacks in patients with relapsing remitting multiple sclerosis (MS), and new symptom progression in primary...